台新藥 (6838)
台新藥 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$0.00M, down 100.0% from a year earlier. EPS over the last four quarters totals -NT$1.26.
Company profile
Data as of 2026-10-18
- Market
- TWSE-listed
- Industry
- Biotech & Medical Care
- Listed
- 2024-08-13
- Founded
- 2010-12-06
- Paid-in capital
- NT$1.51B
- Common shares issued
- 150,977,100
- Legal name
- 台新藥股份有限公司
- Website
- https://www.formosapharma.com
Monthly revenue
Data as of 2026-10-17
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$0.00M | — | -100.0% |
| 2026-08 | NT$0.00M | — | — |
Year to date: +672.8% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | -0.45 |
| 2026 Q1 | -0.10 |
| 2025 Q4 | -0.31 |
| 2025 Q3 | -0.40 |
| 2025 Q2 | 0.43 |
| 2025 Q1 | -0.27 |
| 2024 Q4 | -0.27 |
| 2024 Q3 | -0.29 |
Last four quarters: -NT$1.26
Dividends
Data as of 2026-10-18
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 0.00 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 951 | 0.1% |
| 1,000–5,000 shares | 4,087 | 5.6% |
| 5,001–10,000 shares | 644 | 3.4% |
| 10,001–15,000 shares | 253 | 2.1% |
| 15,001–20,000 shares | 180 | 2.2% |
| 20,001–30,000 shares | 133 | 2.2% |
| 30,001–40,000 shares | 95 | 2.2% |
| 40,001–50,000 shares | 61 | 1.9% |
| 50,001–100,000 shares | 127 | 6.2% |
| 100,001–200,000 shares | 53 | 4.9% |
| 200,001–400,000 shares | 39 | 7.3% |
| 400,001–600,000 shares | 12 | 4.0% |
| 600,001–800,000 shares | 4 | 1.9% |
| 800,001–1,000,000 shares | 3 | 1.8% |
| 1,000,001+ shares | 10 | 54.1% |
TDCC data for 2026-10-16: 10 holders own more than 1,000 lots (54.1% of shares), and 951 hold less than one lot (0.1%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | 5 | 0 | 1 | 6 |
| 2026-10-16 | 26 | 0 | 1 | 27 |
| 2026-10-15 | 66 | 0 | 0 | 66 |
| 2026-10-14 | 14 | 0 | 0 | 14 |
| 2026-10-13 | -22 | 0 | 0 | -22 |
| 2026-10-12 | -6 | 0 | 0 | -6 |
| 2026-10-08 | -20 | 0 | 0 | -20 |
| 2026-10-07 | -18 | 0 | 0 | -18 |
| 2026-10-06 | -4 | 0 | -1 | -5 |
| 2026-10-05 | -35 | 0 | -1 | -36 |
| 2026-10-02 | -32 | 0 | 1 | -31 |
| 2026-10-01 | -32 | 0 | 0 | -32 |
| 2026-09-30 | 10 | 0 | 0 | 10 |
| 2026-09-29 | -48 | 0 | -1 | -49 |
| 2026-09-24 | -129 | 0 | -1 | -130 |
| 2026-09-23 | 162 | 0 | -12 | 150 |
| 2026-09-22 | 7 | 0 | 0 | 7 |
| 2026-09-21 | 14 | 0 | 2 | 16 |
| 2026-09-18 | -55 | 0 | 16 | -39 |
| 2026-09-17 | 37 | 0 | 0 | 37 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net sellers of 55 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$25.30 (2026-10-19); 52-week range NT$22.35–33.30.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.